Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: A population-based follow-up study in the Skaraborg Project

Scandinavian Journal of Primary Health Care

Volumn 25, Issue 4, 2007, Pages 237-243

  Bøg Hansen, Erik ^a,b   Larsson, Charlotte A ^a   Gullberg, Bo ^a   Melander, Arne ^a,c   Boström, Kristina ^a,b   Råstam, Lennart ^a   Lindblad, Ulf ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b RandD Centre Skaraborg Primary Care   (Sweden)

^c Network for Pharmacoepidemiology Foundation   (Sweden)

Author keywords

Acute myocardial infarction; Cardiovascular disease risk factors; Family practice; Hypertension; Primary care; Type 2 diabetes

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIMARY MEDICAL CARE; RISK FACTOR;

EID: 36549062990     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.1080/02813430701706253     Document Type: Article

References (30)

1. Criqui MH, Barrett-Connor E, Holdbrook MJ, Austin M, Turner JD. Clustering of cardiovascular disease risk factors. Prev Med 1980;9:525-33.
2. Bøg-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A, Råstam L. Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project. J Int Med 1998;243:223-32.
3. Kannel WB. Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol 1987;59:80A-90A.
4. 1999 World Health Organization - International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.
5. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 2003;21:1011-53.
6. Swedish Council on Technology Assessment in Health Care. Måttligt förhöjt blodtryck. En systematisk litteraturöversikt [Moderately raised blood pressure. A systematic survey of publications]. SBU-rapport 170; 2004. Stockholm: SBU [SBU, Box 5650, 114 86 Stockholm, Sweden].
7. Berglund G, Isacsson S-O, Rydén L. The Skaraborg Project - a controlled trial regarding the effect of structured hypertension care. Acta Med Scand 1979;/205[Suppl 626]:64-8.
8. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-58.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
10. World Health Organization Expert Committee. Diabetes mellitus. Technical Report Series no 742. Geneva, Switzerland: WHO; 1985.
11. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edn. Geneva: World Health Organization; 1982. p. 123-9.
12. Lindblad U, Råstam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: The Skaraborg Hypertension Project. Scand J Soc Med 1993;1:3-9.
13. Larsson CA, Gullberg B, Merlo J, Råstam L, Lindblad U. Female advantage in AMI mortality is reversed in patients with type 2 diabetes in the Skaraborg Project. Diabetes Care 2005;28:2246-8.
14. Bøg-Hansen E, Lindblad U, Gullberg B, Melander A, Råstam L. Survival in patients with hypertension treated in primary care: A population-based follow-up study in the Skaraborg Hypertension and Diabetes Project. Scand J Prim Health Care 2004;22:222-7.
15. Lee WL, Cape D, Cheung A, Zinman B. Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies. Diabetes Care 2000;23:962-8.
16. Halimi JM, Forhan A, Balkau B, Novak M, Wilpart E, Tichet J, et al. DESIR Study Group. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women? Cardiovasc Risk 2001;8:139-46.
17. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
18. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.
19. Alberti KGMM Zimmet PZfor the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
20. Nilsson P, Theobald H, Journath G, Fritz T. Gender differences in risk factor control and treatment profile in diabetes: A study in 229 Swedish primary heath care centres. Scand J Prim Health Care 2004;22:27-31.
21. Kjellgren KI, Ahlner J, Dahlöf B, Gill H, Hedner T, Säljö R. Perceived symptoms amongst hypertensive patients in routine clinical practice - a population-based study. J Intern Med 1998;244:325-32.
22. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-7.
23. Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlöv P, Brunkstedt I, et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care 2006;24:224-30.
24. Bøg-Hansen E, Lindblad U, Gullberg B, Melander A, Råstam L. Metabolic disorders associated with uncontrolled hypertension: The Skaraborg Hypertension and Diabetes Project. Diabetes Obes Metab 2003;5:379-87.
25. Kvenild K, Romundstad S, Midthjell K, Kruger Ö, Hallan H, Holmen J. Microalbuminuria in treated hypertensives: Only a mirror image of cardiovascular risk? Scand J Prim Health Care 2006;24:145-53.
26. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004;27:2898-904.
27. Ferrara A, Williamson DF, Karter AJ, Thompson TJ, Kim X. Sex differences in quality of health care related to ischemic heart disease prevention in patients with diabetes. Diabetes Care 2004;27:2974-6.
28. Barret-Connor EL, Cohn BA, Wingard DL, Edelstein S. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernado Study. JAMA 1991;265:627-31.
29. Gaede P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999;353:617-22.
30. Agevall S, Fagerberg B, Berglund G, Schmidt C, Wendelhag I, Wikstrand J. for the Risk Factor Intervention Group, Sweden. Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years follow-up. J Intern Med 2001;249:305-14.